Mucosal vaccination with a multivalent, live-attenuated vaccine induces multifactorial immunity against Pseudomonas aeruginosa acute lung infection.
about
Vaccines for Pseudomonas aeruginosa: a long and winding roadA comprehensive analysis of in vitro and in vivo genetic fitness of Pseudomonas aeruginosa using high-throughput sequencing of transposon librariesMulti-Functional Characteristics of the Pseudomonas aeruginosa Type III Needle-Tip Protein, PcrV; Comparison to Orthologs in other Gram-negative BacteriaDeletion of Braun lipoprotein and plasminogen-activating protease-encoding genes attenuates Yersinia pestis in mouse models of bubonic and pneumonic plague.The B lymphocyte differentiation factor (BAFF) is expressed in the airways of children with CF and in lungs of mice infected with Pseudomonas aeruginosaDesign of live attenuated bacterial vaccines based on D-glutamate auxotrophy.Visualization of murine intranasal dosing efficiency using luminescent Francisella tularensis: effect of instillation volume and form of anesthesia.Vaccine immunity to coccidioidomycosis occurs by early activation of three signal pathways of T helper cell response (Th1, Th2, and Th17).Pangenome-wide and molecular evolution analyses of the Pseudomonas aeruginosa species.Collaboration between macrophages and vaccine-induced CD4+ T cells confers protection against lethal Pseudomonas aeruginosa pneumonia during neutropenia.X-ray Irradiated Vaccine Confers protection against Pneumonia caused by Pseudomonas aeruginosaA genetic approach to the development of new therapeutic phages to fight pseudomonas aeruginosa in wound infections.Progress Toward a Human Vaccine Against CoccidioidomycosisPseudomonas aeruginosa outer membrane vesicles modulate host immune responses by targeting the Toll-like receptor 4 signaling pathway.Exogenous remodeling of lung resident macrophages protects against infectious consequences of bone marrow-suppressive chemotherapy.Recent developments for Pseudomonas vaccines.Vaccine development and passive immunization for Pseudomonas aeruginosa in critically ill patients: a clinical update.Protective efficacy of recombinant exotoxin A--flagellin fusion protein against Pseudomonas aeruginosa infection.Flow Cytometric Analysis of Protective T-Cell Response Against Pulmonary Coccidioides Infection.Regionally compartmentalized resident memory T cells mediate naturally acquired protection against pneumococcal pneumonia.Cloning, expression and characterization of recombinant exotoxin A-flagellin fusion protein as a new vaccine candidate against Pseudomonas aeruginosa infectionsPost-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection.
P2860
Q26852817-EBB7C392-93DD-4182-AE48-B6B90637B205Q28493193-9D64CE1C-E1CB-44AD-975B-62C53DA2476DQ30431366-C5B70F21-A497-4268-87DC-1D0980471351Q33603015-E2F50E3F-EA70-4B19-B548-78AD5A3BBE45Q33644527-1CBD70EF-2C1D-4A51-AB88-8CA6E75C6EA7Q33763029-CE2E0E45-42F8-4723-AEB4-FE5C5DB803F1Q34181668-CFD3382A-B3F4-469B-B2CD-870D8D68E3EAQ35671630-727C9F69-F5B8-4F01-A35B-80E435D3FD5CQ35891241-08802707-4808-4169-B394-5FECBDC4AF3FQ36471098-1DE8102D-549A-4FF1-A339-B1BC481244F4Q36583078-440210CF-F52D-4937-B3BA-83B6234408A7Q36586859-DFD211FC-CA31-40E8-A717-63458FAA16E5Q36749818-940DB4B8-F686-49A2-98DE-88DB4972FC0CQ37336004-00BAF797-33BF-48D6-92D0-A007B7EB337AQ37346941-4DD18007-10C7-4C11-BFF3-EC0C3F93F0C7Q37937369-490117AC-C96D-411B-BF03-1B756B40209DQ38210319-0FF575B4-8AE3-464A-BB30-BB0F28151BBEQ38999243-1597669E-82AC-43CC-8367-ACED2ACBA7BDQ40109971-8D9070E3-A833-4558-A343-C97DB1CAF482Q40209420-500FC70E-1EA3-4CDC-A601-076DB12BF67BQ42036438-4C7BE9B9-6109-4B37-8CBC-DC1C085A9669Q47415600-473F65EE-0226-494F-B95B-114FA75A45DA
P2860
Mucosal vaccination with a multivalent, live-attenuated vaccine induces multifactorial immunity against Pseudomonas aeruginosa acute lung infection.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Mucosal vaccination with a mul ...... ruginosa acute lung infection.
@ast
Mucosal vaccination with a mul ...... ruginosa acute lung infection.
@en
type
label
Mucosal vaccination with a mul ...... ruginosa acute lung infection.
@ast
Mucosal vaccination with a mul ...... ruginosa acute lung infection.
@en
prefLabel
Mucosal vaccination with a mul ...... ruginosa acute lung infection.
@ast
Mucosal vaccination with a mul ...... ruginosa acute lung infection.
@en
P2093
P2860
P356
P1476
Mucosal vaccination with a mul ...... ruginosa acute lung infection.
@en
P2093
Akinobu Kamei
Gregory P Priebe
Joanna B Goldberg
Yamara S Coutinho-Sledge
P2860
P304
P356
10.1128/IAI.01139-10
P407
P50
P577
2010-12-13T00:00:00Z